ABSTRACT SUBMISSION FOR THE 2nd INTERNATIONAL CONGRESS

ON MOBILE DEVICES AND SEIZURE DETECTION IN EPILEPSY

ABSTRACT SUBMISSION IS NOW CLOSED

LATE CALL FOR ABSTRACT WILL OPEN ON JUNE 20 (UNTIL JUNE 30)

__________________________________________________________________________________________________________________________________________________

The 2nd International Congress on Mobile Devices and Seizure Detection in Epilepsy (MHSDEpilepsy) invites you to submit an abstract to be considered for inclusion in the Scientific Program of the 2nd International Congress on Mobile Devices and Seizure Detection in Epilepsy. Accepted abstracts will be presented in either thematic Poster Sessions or Oral Sessions presented on September 6-7, 2019.

Please carefully read the Abstract Guidelines below before submission.

Abstracts can only be submitted electronically through this web page.

It is the author's responsibility to submit a correctly edited and accurate abstract. Any errors in spelling, grammar or scientific fact will be reproduced as typed by the author.

Abstracts will be rejected if they contain no data or if the English is unacceptable. All Presenting Authors will receive detailed presentation guidelines when their abstract has been accepted and closer to the Congress.

Kindly note you need to register to the meeting in order to submit an abstract.

Acknowledgement of the receipt of abstract submission will be sent to the Presenting Author's email address immediately upon submission. In addition, all communication in regard to the Scientific Program, acceptance and presentation will be communicated using the Presenting Author’s email.

A / Abstract Information

• Every abstract submission will me made online on the website http://www.mhsdepilepsy2019.com/ : no submission by mail, fax or email will be accepted.
• The Selection Committe reserves the right to refuse abstracts which don't consistent the formal criteria.
• We remind that the autor accepts that the abstract, once accepted, will be presented (orally or on poster) and that it won't be possible, once accepted, to remove it or ask for its removal.
• Deadline for the abstract submission: May 27, 2019 - June 30, 2019.
• Notification of acceptance/rejection will be emailed by the end of June. The Presenting Author will receive all correspondence regarding the abstract status, presentation type, date and time, via the email that is provided in the abstract submission.
• Presenting authors are responsible for arranging and paying for their own registration, travel and hotel arrangements.

​

B / Abstract Guidelines
 

1) Access to your personal depositary space:

- If you already have an account please write your login below;

- If you haven't an account yet, you can get one by clicking on "create your depositary space"

3)  Add you abstract tittle and choose and choose in the drop-down menu :

• Wished type of presentation (Poster or Oral Communication). If your abstract is chosen, the Selection Committee will decide the presentation's type.
• Topic (1/Seizure Detection; 2/Seizure Prediction; 3/Mobile Devices; 4/Decision Support Systems; 5/Telemedicine).

Please carefully read the Abstract Guidelines below before submitting an abstract. Abstracts can only be submitted electronically through this web page.

Abstracts will be rejected if they contain no data or if the English is unacceptable. All Presenting Authors will receive detailed presentation guidelines when their abstract has been accepted and closer to the Congress.

4) Write the name of the first author (surname, name, email, affiliation, [in the 'Affiliation' field, thank you to precise your hospital, your campus or, by default your speciality], City, Country). The affiliation's number will be "1" and check the case "Main author" or "Speaker". The information relative to the abstract will be sent to the first author (who submit the abstract). Click on "New Co-Author" if you want to add co-authors (5 max). It involved that you've the co-authors' autorization.

Acknowledgement of the receipt of abstract submission will be sent to the Presenting Author's email address immediately upon submission. In addition, all communication in regards to the Scientific Program, acceptance and presentation will be communicated using the Presenting Author’s email.

5) Be careful to those elements before submitting your abstract :

• The abstract must be written and presented in English.
• Abstracts must contain original data and meet international ethical standards.
• Case reports that include findings that are significant and have applied appropriate statistical and analytical methods will be considered.
• Previously published and presented abstracts can be submitted but will not be published in the MHSDEpilepsy Program.
• A maximum of 2,000 characters is allowed for the abstract text.
• The abstract title must be in sentence case with no full stop at the end and no underlining.
• Tables and graphs should not be included in the abstract.
• References (maximum of 2) can be included in the body of the text.
• The abstract title and the author(s) or names of institutions are not to be included in the abstract text.
• Standard abbreviations may be employed in the text. Place special or unusual
• abbreviations in parentheses after the full wording at the first time the full wording appears in the body of the text.
• Non-proprietary (generic) names of drugs, written in lower case, are required at the first mention of a drug.
• Trade names are not allowed.

Organization of the Abstract : The abstract should be organized into the following sections:

• Abstract title
• Author and co-authors
• Background
• Materials & Methods
• Results and Conclusions

Topics : Your abstract must belong to one of the topics listed below:

• Seizure detection
• Seizure prediction
• Mobile devices
• Decision support systems
• Telemedicine

​

Consent to Publish : Should your abstract contain identifiable information about a patient, we ask all consent is received before submitting your abstract. Please check the box if you have received consent to publish or if you do not need consent to publish.

Abstract Revisions : Changes to abstracts are accepted only until the submission deadline by using the abstract submission website. After May 27th, 2019, no changes or revisions will be allowed.

Notification of Acceptance : Notification of acceptance/rejection will be emailed by the end of June. The Presenting Author will receive all correspondence regarding the abstract status, presentation type, date and time, via the email that is provided in the abstract submission.

Travel : Presenting authors are responsible for arranging and paying for their own registration, travel and hotel arrangements.

6) You can now preview and save in the drafts your abstract, to modify it before the validation.

7) To submit your abstract, you have to click on "Submit", from this moment, you won't be able to make any modification from your depositary space.